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Computer assisted diagnosis of ovarian cancer in
primary care
Moving closer, but still some way off
William Hamilton professor of primary care diagnostics
Peninsula College of Medicine and Dentistry, Exeter EX2 4SG, UK
More than 6500women are diagnosed with ovarian cancer each
year in the United Kingdom. This cancer has a relatively poor
prognosis—five year survival is 41%.1 Screening is not
available, although a large UK trial is due to report in 2015, so
this may change.2 Currently, the diagnosis is made almost
entirely as a result of women reporting symptoms to primary
care.3 However, several factors make the diagnosis of ovarian
cancer difficult. The cancer is relatively rare—full time general
practitioners (GPs) will encounter it once every five years on
average, so they build up little personal experience of diagnosing
the disease. Many of the symptoms, such as urinary frequency
or abdominal pain, are non-specific, with causes other than
ovarian cancer more likely.4 Furthermore, women are not as
knowledgeable about the symptoms of ovarian cancer as they
are about other cancers.5 This encourages late presentation, with
women unlikely to mention the possibility of ovarian cancer in
the consultation. Contrast this with breast cancer, where most
women finding a breast lump will report it swiftly and will
expect the possibility of cancer to be discussed at the
consultation.
In the linked study (doi:10.1136/bmj.d8009), Hippisley-Cox
and Coupland look at a different aspect of the diagnosis of
ovarian cancer—that of computer assisted diagnosis.6 They
identified the symptoms of ovarian cancer in a large electronic
database, created a predictive algorithm, and then tested it in a
different subset of the database. The algorithm performed well,
with an area under the receiver operating characteristic curve
of 84%. The authors hope that their algorithm could be used
routinely to identify women at high risk of harbouring ovarian
cancer who could then be offered testing. How realistic is this?
There are several stages before computerised support for a
diagnosis of cancer can become a reality. Creation of an
algorithm is generally the first one—they have been created for
several other cancers, such as colorectal cancer.7 Ideally, such
algorithms should be validated in a different dataset from the
one in which they were created because their performance is
generally worse when tested in a second environment. Some of
this poorer performance reflects coding idiosyncrasies peculiar
to each dataset. Several computer and coding systems are in use
in UK general practice, with the Hippisley-Cox algorithm
derived from one of the most common ones. However, primary
care record keeping is far from standardised, especially for
symptoms. Variation between GPs in recording styles would
have a considerable impact on the algorithm. For example, loss
of appetite was recorded in 0.5% of patients in both the
derivation and validation cohorts yet was recorded in 1.5% of
controls in a similar study that examined both written and
computerised records.4 This difference probably reflects
“hidden” information that cannot be extracted by simple
computer searches.8 A change of this size may invalidate the
algorithm. Furthermore, GPs do not record every symptom that
is mentioned in the consultation—much of the time they
document only diagnoses and treatment. Once GPs knew that
their records of symptoms were being incorporated into an
algorithm, their style of record keeping would probably change,
again weakening the current algorithm, although it could be
updated.
We also need to know if these algorithms can easily be
integrated into general practice software. An early attempt put
several computers out of action in a practice in Sheffield.9
Various teams are working on incorporating diagnostic software
into practice computers, so this aspect can probably be solved
satisfactorily, for the popular general practice computer systems
at least. There is also good evidence that GPs are willing to use
algorithms to improve clinical care. Cardiovascular risk
assessment is standard practice in primary care. GPs have also
shown that they are willing to use scoring systems to identify
possible colorectal cancer.10 Several hundred English GPs are
currently piloting a paper based risk scoring system aimed at
identifying lung or colorectal cancers that would not qualify for
urgent investigation under National Institute for Health and
Clinical Excellence (NICE) recommendations.11
Once these hurdles are overcome, it will be important to select
an “action level” for patients identified by any cancer diagnostic
algorithm. False positives—patients in whom the algorithm
identifies possible cancer but who do not have the disease—will
be common. In cancer diagnostics, the action level with the
highest possible sensitivity is usually selected to ensure as few
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cancers as possible are missed. The upper limit is then set when
the false positive rate becomes unacceptably high. The
disadvantages of false positive results can be minimised by
having a simple “second level” test that can refine the risk
further before undertaking more invasive tests. This is
particularly important if an algorithm is used away from the
consultation room. For instance, GPs could run regular sweeps
of their electronic records for patients with symptom patterns
that might represent cancer and invite patients who test
“positive” for additional testing.
Despite its rarity, ovarian cancer may be a sensible choice for
field testing an algorithm. Measurement of Ca 125 is now
thought to be useful in primary care, although it too has false
positives and false negatives.12 Furthermore, GPs in England
now have improved access to transvaginal ultrasound, which
provides a reasonably rapid mechanism for confirming or
rebutting the diagnosis.
Hippisley-Cox and Coupland’s study has taken us one step
closer to computer assisted diagnosis of cancer, although several
steps remain. One final step must take place outside the GP’s
surgery. All systems that aim to improve identification of cancer
in primary care will lead to increased demand for definitive
tests. There is no point in increasing public awareness, as with
recent TV campaigns for bowel cancer, or increasing the
willingness of GPs to investigate, unless additional investigative
services can be provided—and paid for.
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